Evidence map›Paper›PMID 40481316›Full record

ArticleScientific reports2025

Phase and amplitude gradient waveguide coupled metasurfaces.

Yasaman Tanhayivash, Hadi Soofi, Saeid Nikmehr

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yasaman Tanhayivash *Faculty of Electrical and Computer Engineering, University of Tabriz, Tabriz, Iran.
Hadi Soofi *Faculty of Electrical and Computer Engineering, University of Tabriz, Tabriz, Iran. h.soofi@tabrizu.ac.ir.
Saeid Nikmehr *Faculty of Electrical and Computer Engineering, University of Tabriz, Tabriz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper presents a novel silicon-based metasurface-coated one-dimensional (1D) slab waveguide. The proposed idea can easily engineer and mold guided waves into any desired free-space mode and provide the wavefront control of optical metasurfaces, such as out-of-plane beam deflection and focusing. As an example of application and also in order to prove the functionality of the proposed method, we design such a metalens with a focal length of [Formula: see text] nm at 1550 nm. The final results show the electric field distribution at different heights above the waveguide with clear focusing which confirms our design concept. Also, intensity distribution at the focal plane exhibits significant improvement in focal spot size for final design with full width at half-maximum of about 893 nm. It can be found that all the analytical features of this metasurface can be fulfilled at arbitrary frequency-band. In addition, we investigate the beam squinting of the proposed structure at different wavelengths around 1550 nm. We found small beam squinting over the bandwidth. Therefore, the methodology of this paper can be used to reduce the beam squinting of metasurfaces. Actually, the desired main-beam squinting of the proposed metasurface could be obtained by engineering the parameters of the silicon-bars instead of changing the working wavelength. Guided wave driven property of this metasurface makes it a good candidate to integrate with on chip components. The design concept of this paper can be easily extended to any other optical applications in communications with full on-chip integration, such as solid-state LiDAR, remote sensing, displays, etc.

Indexed as

MetalensMetasurfacesOn chip metasurfacePhotonic integrated circuitsWaveguide-driven metasurface

Identifiers

PMID40481316
PMCPMC12144083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.